Mind Medicine Financials
| MNMD Stock | USD 6.70 0.25 3.88% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.0552 | 0.0905 |
|
| |||||
| Current Ratio | 6.89 | 7.2491 |
|
|
The financial analysis of Mind Medicine is a critical element in measuring its lifeblood. Investors should not minimize Mind Medicine's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Mind | Select Account or Indicator |
Please note, the presentation of Mind Medicine's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mind Medicine's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mind Medicine's management manipulating its earnings.
Mind Medicine Stock Summary
Mind Medicine competes with Cybin, GH Research, ATAI Life, Opthea, and Molecular Partners. Mind Medicine Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. Mind Medicine operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | CA60255C8850 |
| CUSIP | 60255C885 60255C109 60255C802 |
| Location | British Columbia; Canada |
| Business Address | One World Trade |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.mindmed.co |
| Phone | 212 220 6633 |
| Currency | USD - US Dollar |
Mind Medicine Key Financial Ratios
| Return On Equity | -0.68 | ||||
| EBITDA | (103.92 M) | ||||
| Net Income | (108.68 M) | ||||
| Cash Per Share | 3.71 X | ||||
| Current Ratio | 13.86 X |
Mind Medicine Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 81.5M | 164.0M | 170.0M | 124.5M | 302.2M | 154.9M | |
| Other Current Liab | 986K | 6.2M | 15.7M | 28.1M | 36.8M | 38.7M | |
| Net Debt | (80.1M) | (133.5M) | (142.1M) | (85.6M) | (251.9M) | (239.3M) | |
| Retained Earnings | (44.6M) | (137.7M) | (194.5M) | (290.2M) | (398.9M) | (378.9M) | |
| Accounts Payable | 2.0M | 4.2M | 2.1M | 4.1M | 2.0M | 2.9M | |
| Cash | 80.1M | 133.5M | 142.1M | 99.7M | 273.7M | 287.4M | |
| Other Current Assets | 1.4M | 7.4M | 7.8M | 4.2M | 7.9M | 5.8M | |
| Total Liab | 5.7M | 12.3M | 19.1M | 46.4M | 60.7M | 63.7M | |
| Total Current Assets | 81.5M | 137.2M | 146.1M | 103.9M | 281.6M | 295.7M | |
| Intangible Assets | 4.7M | 6.9M | 3.7M | 527K | 474.3K | 450.6K |
Mind Medicine Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Income | 4.2K | 27.5K | 730K | 5.6M | 11.6M | 12.1M | |
| Interest Expense | 164K | 359K | 1.5M | 920K | 2.3M | 2.4M | |
| Operating Income | (33.0M) | (96.4M) | (66.3M) | (93.9M) | (103.9M) | (98.7M) | |
| Income Before Tax | (33.9M) | (94.2M) | (56.8M) | (95.7M) | (108.7M) | (103.2M) | |
| Net Income | (34.1M) | (93.0M) | (47.3M) | (95.7M) | (108.7M) | (103.2M) | |
| Ebit | (33.0M) | (93.8M) | (56.8M) | (95.7M) | (86.2M) | (90.5M) | |
| Ebitda | (32.3M) | (91.2M) | (53.6M) | (92.6M) | (103.9M) | (98.7M) |
Mind Medicine Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 73.4M | 53.4M | 8.6M | (42.4M) | 174.0M | 182.7M | |
| Depreciation | 550K | 2.6M | 3.2M | 3.2M | 527K | 500.7K | |
| Net Income | (33.9M) | (93.0M) | (56.8M) | (95.7M) | (108.7M) | (103.2M) | |
| End Period Cash Flow | 80.1M | 133.5M | 142.1M | 99.7M | 273.7M | 287.4M | |
| Free Cash Flow | (23.6M) | (45.8M) | (50.1M) | (64.4M) | (79.1M) | (75.2M) | |
| Other Non Cash Items | 873K | 1.2M | (6.4M) | 8.5M | 15.5M | 16.2M |
Mind Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mind Medicine's current stock value. Our valuation model uses many indicators to compare Mind Medicine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mind Medicine competition to find correlations between indicators driving Mind Medicine's intrinsic value. More Info.Mind Medicine is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Mind Medicine's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Mind Medicine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Mind Medicine Systematic Risk
Mind Medicine's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mind Medicine volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Mind Medicine correlated with the market. If Beta is less than 0 Mind Medicine generally moves in the opposite direction as compared to the market. If Mind Medicine Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mind Medicine is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mind Medicine is generally in the same direction as the market. If Beta > 1 Mind Medicine moves generally in the same direction as, but more than the movement of the benchmark.
Mind Medicine Thematic Clasifications
Mind Medicine is part of several thematic ideas from Pharmaceutical Products to Biotech. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasToday, most investors in Mind Medicine Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mind Medicine's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Mind Medicine growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Mind Medicine March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mind Medicine help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mind Medicine. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mind Medicine based on widely used predictive technical indicators. In general, we focus on analyzing Mind Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mind Medicine's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.68 | |||
| Information Ratio | 0.0156 | |||
| Maximum Drawdown | 28.29 | |||
| Value At Risk | (9.67) | |||
| Potential Upside | 9.98 |
Complementary Tools for Mind Stock analysis
When running Mind Medicine's price analysis, check to measure Mind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mind Medicine is operating at the current time. Most of Mind Medicine's value examination focuses on studying past and present price action to predict the probability of Mind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mind Medicine's price. Additionally, you may evaluate how the addition of Mind Medicine to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |